APLLTD / NSE / Biotechnology & Drugs

Alembic Pharmaceuticals

INR 742.75-2.75 (-0.10%) 1D

Last updated: 2026-06-09T20:31:35.525916+00:00

Price Chart

1Y Price Trend

Open987.4

High1,107.9

Low635.8

Close731.5

Volume2,31,744

Change-255.9

Change %-25.92%

Key Information

Ticker SymbolAPLLTD

Current Price742.75

52-Week High1,107.9

52-Week Low635.8

Market Cap14,449.4

Beta0.93

Volume2,31,744

ISININE901L01018

Day High750

Day Low725.35

Open750

Recommendations

RatingBuy

Target High1,107.8

Target Low635.3

Target Mean2.22

Target Median52.78

Risk Metrics

Overall RiskBalanced risk

Board Risk31.5

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Isha Lamba Joins Alembic Pharmaceuticals as Head – Investor Relations & Corporate Development - hrtoday.in4 days ago

Market news

Isha Lamba Joins Alembic Pharmaceuticals as Head – Investor Relations & Corporate Development hrtoday.in

Alembic Pharmaceuticals Receives USFDA Tentative Approval for Larotrectinib Capsules - Machine Maker4 days ago

Market news

Alembic Pharmaceuticals Receives USFDA Tentative Approval for Larotrectinib Capsules Machine Maker

A-1 Ltd Bags ₹35 Crore Supply Orders; Shares Rise 4.94% - HDFC Sky5 days ago

Market news

A-1 Ltd Bags ₹35 Crore Supply Orders; Shares Rise 4.94% HDFC Sky

Alembic Gets USFDA Approval For Tretinoin Cream - HDFC Sky5 days ago

Market news

Alembic Gets USFDA Approval For Tretinoin Cream HDFC Sky

Alembic gets USFDA nod for Larotrectinib Capsules - scanx.trade5 days ago

Market news

Alembic gets USFDA nod for Larotrectinib Capsules scanx.trade

Alembic Pharma Secures USFDA Tentative Nod for Generic Vitrakvi, Eyes 180-Day Exclusivity - Medical Dialogues5 days ago

Market news

Alembic Pharma Secures USFDA Tentative Nod for Generic Vitrakvi, Eyes 180-Day Exclusivity Medical Dialogues

Alembic Pharmaceuticals fixes July 29 record date for FY26 dividend - scanx.trade7 days ago

Market news

Alembic Pharmaceuticals fixes July 29 record date for FY26 dividend scanx.trade

Alembic Pharma to Acquire 45% Stake in Canadian Venture to Expand Pharma Business in Canada - Medical Dialogues8 days ago

Market news

Alembic Pharma to Acquire 45% Stake in Canadian Venture to Expand Pharma Business in Canada Medical Dialogues